[Intraocular inflammations. A diagnostic and therapeutic challenge].
Pleyer
U
U
Augenklinik des Campus Virchow Klinikum, Charité-Universitätsmedizin, Berlin. uwe.pleyer@charite.de
D000998:Antiviral Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000628:therapy; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011379:Prognosis; D011994:Recombinant Proteins; D014605:Uveitis / Q000175:diagnosis* / Q000628:therapy; D015354:Vision, Low / Q000209:etiology*
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D016572:Cyclosporine
Am J Ophthalmol. 2000 Oct;130(4):492-513
11024423
Br J Ophthalmol. 2003 Apr;87(4):423-31
12642304
Br J Ophthalmol. 2001 Mar;85(3):261-6
11222327
Arch Ophthalmol. 1970 Oct;84(4):451-2
5492449
Ophthalmologe. 2005 Apr;102(4):349-54
15726383
Ophthalmology. 2004 Mar;111(3):491-500; discussion 500
15019324